Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Nat Med. 2017 Oct 6;23(10):1124-1134. doi: 10.1038/nm.4409.
The cancer stem cell (CSC) concept was proposed four decades ago, and states that tumor growth, analogous to the renewal of healthy tissues, is fueled by small numbers of dedicated stem cells. It has gradually become clear that many tumors harbor CSCs in dedicated niches, and yet their identification and eradication has not been as obvious as was initially hoped. Recently developed lineage-tracing and cell-ablation strategies have provided insights into CSC plasticity, quiescence, renewal, and therapeutic response. Here we discuss new developments in the CSC field in relationship to changing insights into how normal stem cells maintain healthy tissues. Expectations in the field have become more realistic, and now, the first successes of therapies based on the CSC concept are emerging.
癌症干细胞(CSC)概念在四十年前被提出,其表明肿瘤的生长类似于健康组织的更新,由少数专门的干细胞提供动力。逐渐清楚的是,许多肿瘤在专门的龛位中存在 CSC,但其鉴定和根除并不像最初希望的那样明显。最近开发的谱系追踪和细胞消融策略为 CSC 的可塑性、静止、更新和治疗反应提供了新的见解。在这里,我们讨论了 CSC 领域的新发展,以及对正常干细胞如何维持健康组织的认识的变化。该领域的期望变得更加现实,现在,基于 CSC 概念的治疗的初步成功正在出现。